Renaud Ronald C JR
Insider CIK 1354434 · PTCT Director · IDIX President & CEO, Director · CMRX Director · AKBA Director · ATRA Director · TBIO See Remarks, Director · CERE President & CEO, Director · IKNA Director · UPB Director · KLRA CEO & President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | M Exercise deriv | 2026-06-09 | 2026-06-11 | 38,094 | — | $0 | 817,826 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | M Exercise | 2026-06-09 | 2026-06-11 | 38,094 | $5.25 | $200.0K | 38,094 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 215,749 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 320,742 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 284,023 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 160,452 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 83,857 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 284,023 | — | $0 | 284,023 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 160,452 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 160,452 | — | $0 | 160,452 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2023-08-03 | 2023-08-07 | 83,857 | $23.96 | $2.01M | 83,857 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-12 | 2023-06-14 | 160,452 | — | $0 | 160,452 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-12 | 2023-06-14 | 160,371 | — | $0 | 160,371 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-12 | 2023-06-14 | 215,749 | — | $0 | 215,749 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-06-23 | 2022-06-27 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-06-23 | 2022-06-27 | 20,500 | — | $0 | 31,500 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 13,419 | — | $0 | 13,419 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2021-12-21 | 2021-12-23 | 13,419 | — | $0 | 13,419 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 500,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 525,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 325,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 1,071,009 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 89,996 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2021-09-14 | 2021-09-14 | 409,913 | $38.00 | $15.58M | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2021-09-14 | 2021-09-14 | 40,909 | $38.00 | $1.55M | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2021-09-14 | 2021-09-14 | 503,231 | $38.00 | $19.12M | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-06-08 | 2021-06-09 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-06-08 | 2021-06-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2021-04-07 | 2021-09-14 | 9,026 | — | $0 | 1,071,009 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2021-04-07 | 2021-09-14 | 9,026 | $7.39 | $66.7K | 503,231 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2021-04-07 | 2021-04-09 | 9,026 | — | $0 | 1,071,009 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2021-04-07 | 2021-04-09 | 9,026 | $7.39 | $66.7K | 503,321 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2021-03-09 | 2021-03-09 | 325,000 | — | $0 | 325,000 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2021-01-14 | 2021-01-14 | 5,638 | — | $0 | 1,080,035 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2021-01-14 | 2021-01-14 | 1 | — | $0 | 89,996 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2021-01-14 | 2021-01-14 | 5,638 | $7.39 | $41.7K | 494,204 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2021-01-14 | 2021-01-14 | 1 | $8.34 | $8 | 494,205 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 53,004 | — | $0 | 1,085,673 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 3 | — | $0 | 89,997 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 3 | $8.34 | $25 | 488,566 | SEC↗ |
| TBIO Translate Bio, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 53,004 | $7.39 | $391.7K | 488,563 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-04-29 | 2020-04-30 | 71,500 | — | $0 | 71,500 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2020-03-03 | 2020-03-05 | 525,000 | — | $0 | 525,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2019-06-20 | 2019-06-24 | 21,000 | — | $0 | 21,000 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2019-03-08 | 2019-03-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 227,272 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 227,272 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 40,909 | — | $0 | 409,913 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 40,909 | — | $0 | 40,909 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-06-20 | 2018-06-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2017-06-28 | 2017-06-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2016-06-24 | 2016-06-28 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2015-06-22 | 2015-06-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2015-01-02 | 2015-01-02 | 12,000 | $51.00 | $612.0K | 12,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-12-17 | 2014-12-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-12-02 | 2014-12-02 | 5,000 | $11.92 | $59.6K | 5,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2014-09-12 | 2014-09-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 110,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 80,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 225,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 10 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 65,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 375,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 500,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 300,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 300,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 400,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | J Other | 2014-06-19 | 2014-07-11 | 89,990 | — | $0 | 89,990 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-06-10 | 2014-06-11 | 20,000 | $25.38 | $507.6K | 20,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | G Gift | 2014-06-04 | 2014-07-11 | 89,990 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-02-11 | 2014-02-12 | 400,000 | — | $0 | 400,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-02-21 | 2013-02-22 | 500,000 | — | $0 | 500,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | M Exercise deriv | 2012-12-14 | 2012-12-17 | 35,000 | — | $0 | 65,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | M Exercise deriv | 2012-12-14 | 2012-12-17 | 39,990 | — | $0 | 10 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | M Exercise | 2012-12-14 | 2012-12-17 | 35,000 | $2.96 | $103.6K | 89,990 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | M Exercise | 2012-12-14 | 2012-12-17 | 39,990 | $2.41 | $96.4K | 54,990 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-03-01 | 2012-03-02 | 375,000 | — | $0 | 375,000 | SEC↗ |